MedTrace Logo

Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea

NCT04567134 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-09-28

No results posted yet for this study

Summary

Our objective of this study is to derive a real incidence of CDI in tertiary hospitals located through Korean peninsula. In order to get a close value to the truth, the study is planned to co-perform with a national study which was proposed in evaluation process to include more hospitals. Along with the incidence of CDI, clinical characteristics and outcome of CDI will be examined and microbiologic characteristics of C. difficile isolates from CDI patients are studied.

Conditions

  • Clostridium Difficile Infection

Sponsors & Collaborators

  • Korean Center for Disease Control and Prevention

    collaborator OTHER_GOV

  • Pfizer

    collaborator INDUSTRY

  • Hanyang University Seoul Hospital

    lead OTHER

Principal Investigators

  • Hyunjoo Pai, M.D., Ph.D. · Hanyang University College of Medicine

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-12-31
Completion
2022-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04567134 on ClinicalTrials.gov